Klotho Neurosciences, Inc.
KLTO
$0.48
$0.049.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.29M | -11.35M | -7.71M | -6.15M | -4.21M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.32M | 6.45M | 3.91M | 3.05M | 2.14M |
| Change in Net Operating Assets | -587.00K | -639.00K | -677.10K | 150.60K | -131.30K |
| Cash from Operations | -5.55M | -5.54M | -4.48M | -2.95M | -2.20M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | -123.50K | -23.30K |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -123.50K | -23.30K |
| Total Debt Issued | 3.35M | 3.62M | 4.54M | 2.42M | 1.22M |
| Total Debt Repaid | -2.85M | -2.85M | -120.00K | -120.00K | -- |
| Issuance of Common Stock | 11.90M | 11.89M | 0.00 | 175.00K | 275.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 500.00K | 500.00K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -44.60K | -36.10K | 593.70K | 658.90K | 778.90K |
| Cash from Financing | 12.85M | 13.12M | 5.01M | 3.13M | 2.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.30M | 7.59M | 533.50K | 60.90K | 48.80K |